Loading…
Loading…
eConsent solution deploys in under four weeks, integrates with any EDC, and delivers affordable, patient‑centric digital consent AUSTIN, TX / ACCESS Newswire / February 26, 2026 / DATATRAK International, Inc.'s (OTC:DTRK) DATATRAK Powered by Fountayn unified eClinical, eSource, and decentralized clinical trial (DCT) platform, announces the release of its standalone eConsent solution designed to help sponsors, CROs, and sites modernize informed consent while reducing startup timelines and technology costs. The new eConsent offering can be deployed in under four weeks and is available as a lightweight, cost‑effective module or as a fully integrated component of the DATATRAK Powered by Fountayn EDC and DCT ecosystem.
Datatrak International (OTCMKTS:DTRK - Get Free Report) and Vuzix (NASDAQ: VUZI - Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends. Valuation and Earnings This table compares
Datatrak eSource was selected after a rigorous evaluation process of various clinical trial software systems. A key factor in the selection was Datatrak's customizable and reliably proven EDC that seamlessly integrates with all other eClinical functions to be a true eSource solution for healthcare and life sciences.
Datatrak eTMF, ePRO/eCOA, and eConsent are selected after a rigorous evaluation process of various eClinical systems for a $6,600,000 CRO contract. The Datatrak eClinical Technology Platform is the only true eSource solution that seamlessly integrates ePRO/eCOA and eConsent with EDC, RTSM, eTMF, and CTMS into one user friendly dashboard with only one user login required to utilize all the key functions of data management for clinical trials.
After seeing Datatrak eTMF, CRO decides to switch its eTMF from a well-known vendor to Datatrak for all its clinical trials across its global organization. Datatrak eTMF seamlessly integrates into eSource dashboards for permissions granted to EDC users to view and upload documents from eTMF and participate in eTMF workflows directly with EDC and eSource dashboards all with one login.
Adoption of Datatrak's eClinical solution enables CRO to actively manage all clinical trial data, processes, and documents on a single platform and dashboard with the first true eSource solution that seamlessly integrates EDC, RTSM, eTMF, CTMS, eConsent, ePRO/eCOA, Imaging Data, Central and Local Labs, Data Imports and Exports, Enterprise level management of Workflows and Timelines. AUSTIN, TX / ACCESS Newswire / October 12, 2025 / Datatrak International (OTC:DTRK) announces that a large European CRO commits to Datatrak's eClinical Technology Platform for a fully integrated all-in-one clinical trial data solution for eSource, EDC, RTSM, eTMF, CTMS, eConsent, ePRO, Enteprise Management for Workflows and Timelines and other solutions.
Dublin, April 23, 2025 (GLOBE NEWSWIRE) -- The "eClinical Solutions Market 2025" report has been added to ResearchAndMarkets.com's offering. The eclinical solutions market size has grown rapidly in recent years. It will grow from $8.29 billion in 2024 to $9.15 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to growth in healthcare digitalization, electronic health records (EHR), increasing regulatory compliance, increased need for efficiency and productivity, and increased healthcare integration. The eclinical solutions market size is expected to see rapid growth in the next few years. It will grow to $15.52 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing interoperability and data exchange, telehealth and remote care, value-based care models, growing demand for population health management, and increasing adoption of precision medicine. Major trends in the forecast period include artificial intelligence (AI) in healthcare, technological advancements, innovative solutions, strategic collaborations, and healthcare integration solutions. The growth of the eclinical solutions market is expected to be fueled by the increasing number of clinical trials. In May 2023, according to ClinicalTrials.gov, the number of registered clinical trials studies increased from 399,499 in 2022 to 437,533, encompassing all 50 states of the United States and 221 countries globally. The surge in clinical trials, with 53% recorded in non-U.S. locations, is poised to drive the growth of the eclinical solutions market during the forecast period. Major companies in the eClinical Solutions market are concentrating on developing innovations, such as a comprehensive clinical trial management solution aimed at streamlining the research and development process, enhancing data integrity, and improving regulatory compliance. For example, in May 2024, EDETEK Inc., a US-based innovative clinical solutions firm, launched CONFORM eClinical Version 5.1, a comprehensive clinical trial management solution designed to enhance and simplify the clinical trial process. This integrated platform includes essential components like electronic data capture, randomization management, and an electronic trial master file, all focused on improving efficiency, data quality, and regulatory compliance. By providing a self-contained system that meets industry standards, CONFORM eClinical Version 5.1 allows sponsors to gain better control over study conduct, resulting in significant cost savings and quicker turnaround times. Major companies in the eClinical Solutions market are concentrating on developing innovations in eClinical Technologies, such as eClinical Platforms, to enhance data management, improve patient engagement, and streamline clinical trial processes. For example, in September 2023, Datacubed Health, a US-based eClinical technology firm, launched its eClinical platform app in China through a partnership with AppInChina for deployment across official Android and Apple app stores. This launch highlights the company's commitment to compliance, as it has established a legal entity in China and obtained the necessary licenses. The app has been tailored to meet local requirements and thoroughly tested for compliance with Chinese network security standards, backed by a secure SaaS infrastructure hosted on AWS Beijing. North America was the largest region in the eclinical solutions market in 2024. The regions covered in the eclinical solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the eclinical solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. Reasons to Purchase:
Phoenix, Arizona--(Newsfile Corp. - September 22, 2021) - The Stock Day Podcast welcomed Datatrak International, Inc. (OTC Pink: DTRK) ("the Company"), a software-as-a-service provider of enterprise cloud-based technologies for the life sciences industry. CEO of the Company, Jim Bob Ward, and Chairman, Alex Tabatabai, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company's background and current projects. "We got involved with Datatrak about five years ago," said Tabatabai. "We...
No recent filings indexed.